-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Yipinhong (300723.SZ) issued an announcement. Guangzhou Lianrui Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for injectable zoledronic acid concentrated solutions approved and issued by the State Drug Administration, involving the product: “Zoledronic Acid Concentrate Solution for Injection”.

Zhitongcaijing·06/23/2025 04:09:04
Listen to the news
Zhitong Finance App News, Yipinhong (300723.SZ) issued an announcement. Guangzhou Lianrui Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for injectable zoledronic acid concentrated solutions approved and issued by the State Drug Administration, involving the product: “Zoledronic Acid Concentrate Solution for Injection”.